Cargando…

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy

BACKGROUND: Early risk stratification of patients with ischemic cardiomyopathy (ICM) and non-ischemic dilated cardiomyopathy (NIDCM) may be beneficial for therapies. METHODS: We retrospectively enrolled all patients admitted for acute heart failure (HF) between January 2019 and December 2021 in Zhon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Wei, Zhang, Meng, Song, Yu, Han, Xueting, Xu, Yamei, Zhou, Jingmin, Ge, Junbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316578/ https://www.ncbi.nlm.nih.gov/pubmed/37400933 http://dx.doi.org/10.1186/s40001-023-01169-5

Ejemplares similares

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models
por: Lu, Danbo, et al.
Publicado: (2019)

Long-Term Prognostic Value of Restitution Slope in Patients with Ischemic and Dilated Cardiomyopathies
por: Dorenkamp, Marc, et al.
Publicado: (2013)

Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy
por: Liu, Yupeng, et al.
Publicado: (2023)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Prognostic value of right atrial strain derived from cardiovascular magnetic resonance in non-ischemic dilated cardiomyopathy
por: Li, Yangjie, et al.
Publicado: (2022)

The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
por: Spänig, Sabine, et al.
Publicado: (2019)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy
por: Taylor, Robin J, et al.
Publicado: (2014)

Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies
por: Canu, Marjorie, et al.
Publicado: (2021)

Prevalence and prognostic relevance of myocardial inflammation and cardiotropic viruses in non-ischemic dilated cardiomyopathy
por: Kažukauskienė, Ieva, et al.
Publicado: (2022)

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2015)

Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
por: Riffel, Johannes H., et al.
Publicado: (2016)

Pathophysiological background and prognostic implication of systolic aortic root motion in non-ischemic dilated cardiomyopathy
por: Aurich, Matthias, et al.
Publicado: (2019)

Left Atrial Volume Determinants in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Mancuso, Frederico José Neves, et al.
Publicado: (2015)

Statistical suggestions for long-term outcomes for non-ischemic dilated cardiomyopathy
por: Agstam, Sourabh, et al.
Publicado: (2021)

Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy
por: Liu, Muyin, et al.
Publicado: (2023)

Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy
por: Zhou, Mei, et al.
Publicado: (2023)

Prognostic implications of myocardial fibrosis and troponin levels measured by a highly sensitive assay in non-ischemic cardiomyopathy
por: Yang, Eric Y, et al.
Publicado: (2016)

Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
por: Wang, Yongchao, et al.
Publicado: (2023)

Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy
por: Cittar, Marco, et al.
Publicado: (2021)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
por: Shekha, Karthik, et al.
Publicado: (2005)

The association between ECV and microcirculation perfusion abnormalities in non-ischemic dilated cardiomyopathy
por: Ali, Aamir, et al.
Publicado: (2014)

Statistical suggestions for long-term outcomes of non-ischemic dilated cardiomyopathy patients
por: Bursa, Nurbanu
Publicado: (2021)

Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
por: Hildebrandt, Lea, et al.
Publicado: (2022)

Impact of implantable cardioverter defibrillator on survival in patients with non‐ischemic dilated cardiomyopathy
por: Kataoka, Naoya, et al.
Publicado: (2023)

Accurate Classification of Non-ischemic Cardiomyopathy
por: Wang, Yifan, et al.
Publicado: (2023)

Left ventricle restoration in end stage ischemic dilated cardiomyopathy
por: Jonjev, Z
Publicado: (2013)

Comparison of periodontal parameters between patients with ischemic and dilative cardiomyopathy
por: Ziebolz, Dirk, et al.
Publicado: (2021)

Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy
por: Yi, Jeong-Eun, et al.
Publicado: (2020)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Can 3D RVEF be Prognostic for the Non-Ischemic Cardiomyopathy Patient but Not the Ischemic Cardiomyopathy Patient? A Cardiovascular MRI Study
por: Gill, Sartaj S., et al.
Publicado: (2019)

Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy
por: Yu, Ziqing, et al.
Publicado: (2017)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Native left ventricular myocardial T(1) spatial heterogeneity in non-ischemic dilated cardiomyopathy
por: Kashem, Abyaad, et al.
Publicado: (2016)

Post-transcriptional modifications of VEGF-A mRNA in non-ischemic dilated cardiomyopathy
por: Kowalczyk, Jacek, et al.
Publicado: (2007)

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020)

Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
por: Rieger, Angela C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jqi4kcvpkuhbaah82hb7grcpli